-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Deciphera Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
- Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.76M, a 3.18% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $16.6M, a 103% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $16.4M, a 264% increase from 2022.
- Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.51M, a 3894% increase from 2021.
- Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $113K, a 97.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)